GSK-3 Inhibitors: Innovations, Market Trends, and Global Outlook

Ajouter une nouvelle offre d'emploi Health

2025-11-18 17:32:34

Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase involved in numerous cellular processes such as metabolism, neurogenesis, and apoptosis. Dysregulation of GSK-3 has been associated with diseases including neurodegenerative disorders, cancer, diabetes, and psychiatric conditions. Recent advances in GSK-3 inhibitor Drugs that selectively modulate GSK-3 activity are paving the way...

0 Commentaires 0 Parts 55 Vue 0 Aperçu